SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > Free Zone > Penny Trading - Technical > MOMO'S BREAKOUT BOARD

DOMK IRiPAD Charger will be the second product

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
pivotpoint1 Member Profile
Member Level 
Followed By 245
Posts 43,299
Boards Moderated 5
Alias Born 02/15/12
160x600 placeholder
Advertisement
Shire Mounts Bid Worth $30 Billion For U.s. Biotech
Dublin-based Shire made a hostile offer worth $30.6 billion for rare-disease-treatment maker Baxalta, the latest example of a foreign company using its tax-friendly status to go after a U.S. firm.
More Top Equities Stories Of The Day
U.S. Stock Futures, European Equities Drop as China Rallies
Procter & Gamble Sees Muted Outlook -- 2nd Update
Uber Crosses $50 Billion Valuation
Sprint Beats Estimates as Customer Base Grows
Need a $3 Million Home Loan? J.P. Morgan Just Made It Easier
Royal BAM Ireland Gets Microsoft Contract
Shire Offers to Buy Baxalta for $30 Billion -- Update
U.S. Hot Stocks: Hot Stocks to Watch
pivotpoint1 Member Level  Friday, 08/09/13 09:02:24 AM
Re: None
Post # of 1572224 
DOMK IRiPAD Charger will be the second product developed by DoMark for the Apple iPad. Unlike any other product in the market currently, the IRiPad Charger utilizes patented infrared and solar technology designed to improve functionality for the heavy user. While taking advantage of new landmark technology and incorporating sophisticated light weight design, Management expects great success in capturing a share of the $2.3 billion iPad accessories market.

DoMark has already developed an infrared/solar charger case for the Apple iPhone and Samsung Galaxy III and S4 Smartphones which are to be launched in August 2013.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist